MiniMed (MMED) Other financing activities (2025 - 2026)
MiniMed (MMED) posted Other financing activities of $334.0 million for Q2 2026, up 65.35% quarter-over-quarter from $202.0 million in Q3 2025, and up 1436.0% YoY from $21.7 million in Q2 2025.
Powered by 
Analysis
MiniMed (MMED) Other financing activities (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Other financing activities data on file, last reported at $334.0 million in Q2 2026.
- For the quarter ending Q2 2026, Other financing activities rose 1436.0% year-over-year to $334.0 million; the trailing twelve-month figure through Jul 2026 stood at $511.0 million (changed N/A YoY), and the FY2026 full-year result was $538.0 million, up 4383.33% from the prior year.
- Other financing activities was $334.0 million for Q2 2026 at MiniMed, up from $202.0 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $334.0 million in Q2 2026 to a low of -$25.0 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | MiniMed | 6.55 Bn | 6.34 Bn | 465.00 Mn |